Type II hypersensitivity

1,152,342views

Type II hypersensitivity

Watch later

Watch later

Inflammation
Wound healing
Shock: Clinical
Type II hypersensitivity
Type I hypersensitivity
Type IV hypersensitivity
Type III hypersensitivity
Cystic fibrosis
Muscular dystrophy
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Respiratory alkalosis
Metabolic alkalosis
Hypoxia
Oncogenes and tumor suppressor genes
Hyperplasia and hypertrophy
Atrophy, aplasia, and hypoplasia
Metaplasia and dysplasia
Ischemia
Free radicals and cellular injury
Myocardial infarction
Hypertension
Cushing syndrome
Pheochromocytoma
Coarctation of the aorta
Hypotension
Chronic venous insufficiency
Deep vein thrombosis
Shock
Tetralogy of Fallot
Persistent truncus arteriosus
Ventricular septal defect
Atrial septal defect
Patent ductus arteriosus
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
Aortic valve disease
Pulmonary valve disease
Tricuspid valve disease
Mitral valve disease
Cor pulmonale
Heart failure
Endocarditis
Myocarditis
Rheumatic heart disease
Pericarditis and pericardial effusion
Atrioventricular block
Bundle branch block
Ventricular tachycardia
Premature ventricular contraction
Ventricular fibrillation
Premature atrial contraction
Atrial flutter
Atrial fibrillation
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Coronary artery disease: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Cardiomyopathies: Pathology review
Supraventricular arrhythmias: Pathology review
Heart failure: Pathology review
Valvular heart disease: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Pericardial disease: Pathology review
Hypertension: Pathology review
Shock: Pathology review
Endocarditis: Pathology review
Hyperthyroidism
Hypothyroidism
Hyperparathyroidism
Hypercalcemia
Hypoparathyroidism
Hypocalcemia
Diabetes mellitus
Diabetic nephropathy
Hypopituitarism
Hyperpituitarism
Diabetes insipidus
Hyperthyroidism: Pathology review
Adrenal insufficiency: Pathology review
Hypothyroidism: Pathology review
Diabetes mellitus: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Hypopituitarism: Pathology review
Diabetic retinopathy
Peptic ulcer
Ulcerative colitis
Crohn disease
Bowel obstruction
Gallstone ileus
Abdominal hernias
Inguinal hernia
Small bowel ischemia and infarction
Diverticulosis and diverticulitis
Appendicitis
Jaundice
Cirrhosis
Portal hypertension
Gallstones
Acute cholecystitis
Chronic cholecystitis
Acute pancreatitis
Chronic pancreatitis
Malabsorption syndromes: Pathology review
Inflammatory bowel disease: Pathology review
Esophageal disorders: Pathology review
Diverticular disease: Pathology review
Pancreatitis: Pathology review
Jaundice: Pathology review
Cirrhosis: Pathology review
Iron deficiency anemia
Sideroblastic anemia
Autoimmune hemolytic anemia
Sickle cell disease (NORD)
Aplastic anemia
Megaloblastic anemia
Thrombotic thrombocytopenic purpura
Disseminated intravascular coagulation
Chronic leukemia
Acute leukemia
Non-Hodgkin lymphoma
Hodgkin lymphoma
Polycythemia vera (NORD)
Mastocytosis (NORD)
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Leukemias: Pathology review
Systemic lupus erythematosus
Poststreptococcal glomerulonephritis
DiGeorge syndrome
Hereditary angioedema
Complement deficiency
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Osteoporosis
Spina bifida
Intracerebral hemorrhage
Subarachnoid hemorrhage
Epidural hematoma
Subdural hematoma
Alzheimer disease
Parkinson disease
Hypermagnesemia
Hyperkalemia
Hypokalemia
Hypomagnesemia
Hyponatremia
Hypernatremia
Minimal change disease
Focal segmental glomerulosclerosis (NORD)
Membranoproliferative glomerulonephritis
IgA nephropathy (NORD)
Rapidly progressive glomerulonephritis
Alport syndrome
Kidney stones
Acute pyelonephritis
Chronic pyelonephritis
Chronic kidney disease
Renal artery stenosis
Nephritic syndromes: Pathology review
Renal failure: Pathology review
Nephrotic syndromes: Pathology review
Acute respiratory distress syndrome
Asthma
Emphysema
Chronic bronchitis
Bronchiectasis
Restrictive lung diseases
Sarcoidosis
Pneumonia
Pneumothorax
Pleural effusion
Pulmonary embolism
Pulmonary hypertension
Pulmonary edema
Respiratory distress syndrome: Pathology review
Pneumonia: Pathology review
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review

Transcript

Watch video only

Content Reviewers

Having a hypersensitivity means that the immune system is reacting to something in a way that damages the body rather than protecting it.

There are four different types of hypersensitivities, and the second type or type II hypersensitivity is sometimes called cytotoxic hypersensitivity because a lot of disorders caused by this hypersensitivity involve antibody mediated destruction of healthy cells.

These disorders tend to be tissue specific meaning that the antibodies are generally specific to one type of tissue or organ.

There are other antibody-mediated hypersensitivities that are systemic, and these are generally Type III hypersensitivities.

Our immune system is setup to fight anything that is considered “non-self” right? Anything that’s not “self”, or you.

This works in large part because of a process called central tolerance which is when developing immune cells that are self-reactive get destroyed or inactivated, whereas immune cells that aren’t are allowed to survive.

This happens while they are still in their primary lymphoid organs, which is the thymus for T cells and the bone marrow for B cells.

This process, though, is not perfect and some self-reactive B and T cells will escape.

These escaped self-reactive cells can then attack healthy tissue and result in autoimmune disease.

In type II hypersensitivity these escaped self-reactive B cells become activated and produce IgM or, with the help of CD4 positive T helper cells, IgG antibodies that attach to antigens on host cells.

There are two type of antigens involved with type II hypersensitivity: intrinsic meaning an antigen the host cell normally makes or extrinsic which is an antigen from an infection or even some medications, like penicillin that gets attached to the host cell.

Alright so let’s say a drug, like penicillin, binds to a red blood cell - well it becomes an extrinsic antigen.

An IgG or more rarely an IgM antibody that is penicillin specific might bind to the penicillin molecule, creating an antigen-antibody complex.

Now it’s worth mentioning that antigen-antibody complexes can happen in the course of a normal infection, but its when an antibody is complexed to host tissue, that things start to become a problem.

The first cytotoxic mechanism of type II hypersensitivity is activation of the complement system.

The complement system is a family of small proteins that work in an enzymatic cascade to fight off bacterial infections using a variety of mechanisms.

In this case, the IgG or IgM antibodies activate complement proteins which ultimately will kill the red blood cell bound to penicillin which is complexed now with IgG or IgM.

The process gets started when C1, the first of the complement proteins, which binds the Fc portion of the antibody.

C1 then engages other members of the complement family - C2 through C9, some of which are activated by being cleaved or chopped by an enzyme.

The cleaved fragments C3a, C4a, and C5a act as chemotactic factors, meaning they attract certain cells, in this case neutrophils.

Once neutrophils join the party, they degranulate or dump a bunch of enzymes like peroxidase, myeloperoxidase, and proteinase 3 which all help generate little oxygen radicals that are highly cytotoxic to cells and can cause tissue damage.

When it comes to drug reactions, like penicillin, Type II hypersensitivity can result in hemolytic anemia (sometimes called autoimmune hemolytic anemia), as well as thrombocytopenia, or neutropenia, since these are the blood cell types that are often affected.

This mechanism is also involved in diseases like Goodpasture’s syndrome, where antibodies bind to intrinsic antigens on collagen of the basement membrane in their glomeruli in the kidney or their alveoli in the lungs, rather than extrinsic antigens in the penicillin example.

The second cytotoxic mechanism requires us to follow the complement system through to the end, that said, C5b, and C6-C8, and a bunch of C9 come together to form the membrane attack complex, or MAC.

Key Takeaways

Type II hypersensitivity is a type of immune response in which the immune system attacks the body's own cells or tissues. Type II hypersensitivity is mediated by antibodies, such as IgG and IgM, directed against antigens on host cells, which cause cell and tissue destruction by complement activation or antibody-dependent cell-mediated cytotoxicity. Examples of Type II hypersensitivity reactions include blood transfusion reactions, erythroblastosis fetalis, and autoimmune hemolytic anemia. Treatment options may include avoiding the tigger, and immunosuppressive medications such as systemic glucocorticoids.